These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28856476)

  • 1. Impact of monocyte-macrophage inhibition by ibandronate on graft function and survival after kidney transplantation: a single-centre follow-up study over 15 years.
    Tillmann FP; Grotz W; Rump LC; Pisarski P
    Clin Exp Nephrol; 2018 Apr; 22(2):474-480. PubMed ID: 28856476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early conversion from CNI to sirolimus on outcomes in kidney transplant recipients with allograft dysfunction.
    Paoletti E; Ratto E; Bellino D; Marsano L; Cassottana P; Cannella G
    J Nephrol; 2012; 25(5):709-18. PubMed ID: 22038336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of selected factors on long-term kidney graft survival--a multivariable analysis.
    Zukowski M; Kotfis K; Kaczmarczyk M; Biernawska J; Szydłowski L; Zukowska A; Sulikowski T; Sierocka A; Bohatyrewicz R
    Transplant Proc; 2014 Oct; 46(8):2696-8. PubMed ID: 25380897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over 5 Years of Excellent Graft Kidney Function Determinants: Baskent University Experience.
    Sayin B; Ozdemir A; Ayvazoglu Soy EH; Kirnap M; Akdur A; Moray G; Haberal M
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):75-77. PubMed ID: 30777527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function.
    Lenihan CR; O'Kelly P; Mohan P; Little D; Walshe JJ; Kieran NE; Conlon PJ
    Ren Fail; 2008; 30(4):345-52. PubMed ID: 18569905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival.
    Eide IA; Halden TAS; Hartmann A; Dahle DO; Åsberg A; Jenssen T
    Transplantation; 2017 Jun; 101(6):1282-1289. PubMed ID: 27362306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
    Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
    Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
    Adekoya AO; Halawa A
    Exp Clin Transplant; 2016 Feb; 14(1):32-7. PubMed ID: 26862822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival.
    Prasad GVR; Ananth S; Palepu S; Huang M; Nash MM; Zaltzman JS
    Kidney Int; 2016 May; 89(5):1119-1124. PubMed ID: 27083285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to everolimus in kidney transplant recipients: to believe or not believe?
    Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A
    Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of kidney transplant precocity in graft long-term survival.
    Malho A; Malheiro J; Fonseca I; Martins LS; Pedroso S; Almeida M; Dias L; Castro Henriques A; Cabrita A
    Transplant Proc; 2012 Oct; 44(8):2344-7. PubMed ID: 23026589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation.
    Roodnat JI; Hilbrands LB; Hené RJ; de Sévaux RG; Smak Gregoor PJ; Kal-van Gestel JA; Konijn C; van Zuilen A; van Gelder T; Hoitsma AJ; Weimar W
    Transplantation; 2014 Jul; 98(1):47-53. PubMed ID: 24521775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
    Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
    Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and sustained improvement of calcification propensity score (serum T
    Smerud KT; Åsberg A; Kile H; Pasch A; Dahle DO; Bollerslev J; Godang K; Hartmann A
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28972673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.